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VARIATION IN THE BACTERICIDAL/PERMEABILITY INCREASING PRO-
TEIN GENE INFLUENCES THE RISK OF DEVELOPING RAPID AIRFLOW
DECLINE AFTER HEMATOPOIETIC CELL TRANSPLANTATION
Chien, J.W., Zhao, L.P., Hansen, J.A., Fan, W.H., Parimon, T.,
Clark, J.G. Fred Hutchinson Cancer Research Center, Seattle, WA.
Signiﬁcant airﬂow decline affects up to 26% of patients who
receive a hematopoietic cell transplant. Since innate immunity is
involved in the biology of graft versus host disease and common
airways diseases, we screened 15 genes in this pathway using a
haplotype approach to identify genes that are critical to the devel-
opment of this syndrome. The presence or absence of signiﬁcant
airﬂow decline, deﬁned as a 	5% annualized rate of one second
forced expiratory volume decrease after transplant, was determined
in discovery (n 363) and validation (n 209) cohorts. Sixty-nine
haplotype tagging single nucleotide polymorphisms were selected
for the initial screen. Expression of the candidate gene was dem-
onstrated by detecting gene transcript and protein in malignant
and normal small airway epithelial cells. In the discovery cohort,
133 patients developed signiﬁcant airﬂow decline. Four patient and
donor bactericidal permeability increasing (BPI) haplotypes were
signiﬁcantly associated with a 2 to 3-fold increased risk for devel-
oping signiﬁcant airﬂow decline (P  .004 to .038). This associa-
tion was conﬁrmed in the validation cohort, which had 66 patients
with signiﬁcant airﬂow decline, with 9 signiﬁcant haplotypes (P 
.013 to .043). Patient haplotypes on the lipopolysaccharide binding
protein (LBP) gene, located directly adjacent to the BPI gene on
chromosome 20, were also associated with the phenotype. Fine-
mapping studies of the 1-mb region surrounding the BPI gene
indicated there was no evidence of extended haplotype blocks and
the genomic region of highest association was conﬁrmed to be
within the BPI gene. BPI gene transcript and protein was detected
for the ﬁrst time in airway epithelial cells. These results indicate
that genetic variation affecting the BPI gene signiﬁcantly inﬂu-
ences the risk for developing rapid airﬂow decline after hemato-
poietic cell transplantation and may represent a novel therapeutic
target for this form of airways disease.
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IN VIVO TRAFFICKING AND PROLIFERATION OF NATURAL KILLER
CELLS IN MURINE MODELS OF BONE MARROW TRANSPLANTATION
Olson, J.A., Negrin, R.S. Stanford University, Stanford, CA.
The high incidence of graft versus host disease (GVHD) as a
complication of allogeneic hematopoietic cell transplantation has
limited its overall effectiveness in treating hematologic malignan-
cies. It has been shown that natural killer (NK) cells have the
capability of suppressing the development of GVHD while induc-
ing an anti-tumor response. Little is known about the trafﬁcking
patterns of NK cells following hematopoietic cell transplantation,
their proliferation or how long they persist in vivo. We investi-
gated the trafﬁcking patterns of NK cells in vivo in allogeneic and
syngeneic bone marrow transplant settings using a novel in vivo
bioluminescence imaging (BLI) technique. Freshly isolated NK
cells from FVB L2G85 gfp/luc transgenic mice, which can be
imaged by BLI, were transplanted along with T-cell depleted bone
marrow on day 0 into lethally irradiated BALB/c mice. In vivo and
ex vivo BLI of the transplanted mice on successive days post-
transplant indicated that in the allogeneic setting, NK cells trafﬁc
to distinct lymphoid organs, namely the peripheral and mesenteric
lymph nodes and spleen. The in vivo bioluminescent signal was
2.75-fold greater on day 6 than on day 2, indicating a signiﬁcant in
vivo expansion of the NK cells. In the syngeneic setting, NK cell
trafﬁcking to distinct lymphoid organs was not detected and min-
imal NK cell proliferation was visible by ex vivo BLI. To determine
the extent of NK cell proliferation in vivo, freshly isolated NK cells
were labeled with CFSE and transplanted into allogeneic and
syngeneic recipients. On day 5, FACS analysis of splenocytes
showed that 90% of donor CFSE labeled NK cells had divided in
the recipient spleen, undergoing at least 6 divisions. In the synge-
neic recipient, 59% of the CFSE labeled NK cells had divided,
with only 4 cell divisions visible. This corresponds to the BLI
signal and timing patterns seen in the spleens of both recipient
animals in ex vivo BLI images. These studies have characterized
the in vivo trafﬁcking and proliferation of NK cells in murine bone
marrow transplantation models. Continuing studies will aim to
identify what is responsible for the initiation and continuation of
allogeneic proliferation, and whether the in vivo expansion is
driven by NK cell receptor-ligand interactions or MHC class I
differences. Understanding NK cell trafﬁcking and proliferation
could provide novel insights into enhancing function of both in-
nate and adoptively transferred NK cells.
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DONOR CD8 T CELLS FACILITATE ENGRAFTMENT AND MEDIATE GVL
WITHOUT GVHD IN RECIPIENTS CONDITIONED WITH ANTI-CD3 MAB
Zhang, C.1, Lou, J.1, Huang, T.1, Todorov, I.1, Cao, Y.2, Contag, C.2,
Kandeel, F.1, Forman, S.1, Zeng, D.1 1. The Beckman Research Institute
of City of Hope, Duarte, CA; 2. Stanford University School of Medicine,
Stanford, CA.
Donor CD8 T cells play a critical role in facilitating engraft-
ment and mediating graft versus leukemia (GVL), but also induce
severe graft versus host disease (GVHD) in recipients conditioned
with total body irradiation (TBI) in murine as well as human
allogeneic hematopoietic cell transplantation (HCT). In the cur-
rent study, in a murine MHC-mismatched model of C57BL/6 or
FVB/N donor to BALB/c recipient, three injections of 5-20  106
donor CD8 T cells in combination with one injection of 50-
100  106 donor bone marrow (BM) cells induced complete
chimerism without signs of GVHD or lymphocyte inﬁltration in
skin or gut tissues in BALB/c recipients conditioned with anti-
CD3 mAb 7 days before donor cell injections. In contrast, the same
doses of donor CD8 T and BM cells induced lethal GVHD with
severe tissue inﬁltration in recipients conditioned with sublethal
TBI. Although donor CD8 T cells migrated to thymus in both
TBI-conditioned and anti-CD3-conditioned recipients, donor
CD8 T cells did not cause thymus tissue destruction in anti-
CD3-conditioned recipients, and the yield of total and
CD4CD8 thymocytes in anti-CD3-conditioned recipients was
100 fold higher than in TBI-conditioned recipients 30 days after
transplantation. In addition, donor CD8 T cells eliminate BCL1
tumor cells without causing GVHD in anti-CD3-conditioned re-
cipients. Using in vivo and in vitro bioluminescent imaging, we
found that donor CD8 T cells from luciferase transgenic mice
expanded rapidly and inﬁltrated GVHD target tissues (i.e. gut,
liver and lung) in TBI-conditioned recipients, but donor CD8 T
cell expansion in anti-CD3-conditioned recipients was conﬁned in
lympho-hematological tissues, especially in mesenteric lymph
nodes and Peyer’s patches. This conﬁnement was associated with
reduced production of pro-inﬂammatory cytokines (i.e. TNF-
)
and increased production of anti-inﬂammatory cytokines (i.e. IL-4
and IL-10) in anti-CD3-conditioned recipients compared to TBI-
conditioned recipients early after transplantation. Host residual
NKT cells appeared to be the source of IL-4 and IL-10 production
in anti-CD3-conditioned recipients. These results demonstrate
that anti-CD3-conditioning separates GVL from GVHD via con-
ﬁning donor CD8 T cell expansion to host lympho-hematolog-
ical tissues. This radiation-free and GVHD preventive regimen
may be useful for allogeneic HCT in treating malignancies and
autoimmune diseases, as well as transplantation tolerance induc-
tion.
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IN VIVO KINETICS OF ACUTE GRAFT-VERSUS-HOST DISEASE IN CON-
DITIONED VS. UNCONDITIONED HOSTS
Beilhack, A.1, Wai, L.-E.1, Schulz, S.3, Beilhack, G.F.1, Nishimura, R.1,
Baker, E.M.1, Herman, E.I.1, Landan, G.1, Olson, J.A.1, Baker, J.1,
Contag, C.H.2, Negrin, R.S.1 1. Division of Blood & Marrow Trans-
plantation, Stanford University; 2. Department of Pediatrics, Stanford
University; 3. Institute of Pathology, Technical University Munich,
Germany.
Acute graft-versus-host disease (aGVHD) is a major limitation
for the broader applicability of allogeneic hematopoietic cell trans-
plantation (aHCT). Here we asked how the conditioning regimen
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affects donor T cell expansion, activation and migration. We com-
pared lethally irradiated vs. non-irradiated Balb/c (H-2d) mice that
received allogeneic luciferase FVB/N T cells (H-2q). In vivo
bioluminescence imaging (BLI) visualized the kinetics of aGVHD
and guided more detailed analyses. Irradiated wild type Balb/c,
Balb/c Rag/ and Balb/c Rag/cchain/ aHCT recipients
displayed comparable kinetics of aGVHD initiation in lymphoid
organs until day 3 and started intestinal inﬁltration by day 4,
skin and liver inﬁltration by day 5-6. All mice succumbed to
lethal aGVHD within two weeks after aHCT. Non-irradiated
Balb/c wild type recipients did not develop aGVHD. BLI revealed
the process of graft rejection after initial signal increase over lymphoid
organs by day3. In contrast donor cells overcame host resistance in
non-irradiated Balb/c Rag/ and Balb/c Rag/cchain/ mice.
However, despite proliferation in lymphoid organs, inﬁltration of
aGVHD target tissues was delayed. Balb/c Rag/ displayed moder-
ate and Balb/c Rag/cchain/ mice even weaker intestinal inﬁl-
tration on day 6. FACS analysis revealed that donor T cell subsets
were less activated in non-irradiated as compared to irradiated hosts.
Non-irradiated Balb/c Rag/cchain/ mice succumbed to lethal
aGVHDwithin twomonths after aHCT. Balb/c Rag/mice did not
die from aGVHD suggesting that host NK cells controlled alloreac-
tive T cells. In summary host conditioning exacerbates aGVHD by
increased alloreactive T cell activation and recruitment to aGVHD
target tissues.
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EPIDERMAL DENDRITIC CELL DEPLETION WITH MYELOABLATIVE
CONDITIONING THAT DOES NOT RECOVER POST TRANSPLANT
Hofmeister, C.C.1, Peterson, A.1, Tara, K.2, Stiff, P.1, Curry, J.1,
Nickoloff, B.J.1 1. Loyola Cardinal Bernardin Cancer Center, Maywood,
IL; 2. Lake Erie College of Osteopathic Medicine, Bradenton, FL.
Introduction: Cutaneous graft-versus-host disease (GVHD) is
an antigen presenting cell mediated process which leads donor T
lymphocytes to presumably target keratinocyte progenitor cells at
the dermal-epidermal junction. In the absence of inﬂammation,
epidermal dendritic cells (a.k.a. Langerhans cells or LCs) can
self-renew for long periods of time without the requirement for a
bone-marrow derived blood-borne precursor. Murine models have
suggested that depletion of host LCs pretransplant prevents cuta-
neous GVHD. We sought to determine epidermal dendritic cell
density pre-transplant, post-transplant, and with the onset of acute
GVHD. Methods: We reviewed all skin biopsies performed on
2101 stem cell transplants patients at Loyola University Medical
Center from 1995-2005. From these parafﬁn-embedded blocks, 20
randomly selected acute GVHD biopsies, all 17 biopsies of non-
GVHD rashes in post allograft patients, and 12 normal skin biop-
sies from reduction mammoplasties were obtained. In addition as
part of a prospective trial, 14 patients underwent punch biopsies
from December 2004 to August 2005 of grossly normal skin before
and immediately following the completion of their conditioning
regimens. All biopsies were stained for CD1a (LC marker) and the
number of suprabasal stained cells per high power ﬁeld (HPF) were
counted by a dermatopathologist. Results: Total body irradiation
containing (TBI) conditioning regimens nearly completely elimi-
nated epidermal LCs by the day of transplant. In comparison to
normal skin (44 CD1a cells  4.7 [95% CI]), acute GVHD
lesions showed a depletion of epidermal LCs (3.7 CD1a cells 
3.2 [95% CI]), but so did biopsies obtained post allograft without
GVHD (6.5 CD1a cells  3.6 [95% CI]). Conclusions: My-
eloablative conditioning regimens deplete epidermal LCs and this
reduction may remain post engraftment. UV dermatitis, topical
steroids or tacrolimus, viral infections (HPV, HIV), and GVHD all
induce LC depletion. The mechanism for this depletion is un-
known but mediators such as TNF-
 and IL-1 have induced LC
migration in murine models (Roake JE, J Exp Med, 1995). Our data
suggest that pretransplant LC depletion in humans will not prevent
cutaneous GVHD. Future studies will need to be performed to
determine the origin of LCs in post allograft patients.
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HOST LANGERHANS CELLS (LCs) CAN BE THERAPEUTICALLY MANIP-
ULATED IN VIVO WITH IMIQUIMOD (TLR7 AGONIST) TO AUGMENT
DLI-MEDIATED GVH AND GVL REACTIVITY
Skarica, M., Radojcic, V., Luznik, L. Sidney Kimmel Comprehensive
Cancer Center at Johns Hopkins, Baltimore, MD.
We recently found in murine models that after MHC-matched
allografting, the residual host LCs, the major dendritic cells (DCs)
of the skin, survive in epidermis despite the presence of large
numbers of peripheral donor T cells in the graft and conversion to
the full donor DC chimerism in blood. This observation led us to
hypothesize that in vivo manipulation of residual host LCs, which
persist in complete donor chimeras after MHC-matched allograft-
ing, may have a central role in augmenting DLI-mediated alloim-
mune responses. We tested our hypothesis in two murine models
of MHC-matched allografting. To manipulate T cell-LC interac-
tion in vivo we used the Toll-like receptor 7 (TLR7) ligand imi-
quimod. Topical application of imiquimod is known to augment in
situ maturation of the LCs and enhance their emigration from the
skin to the skin-draining lymph nodes (LNs). We ﬁrst tracked the
in vivo fate of DLI-derived T cells after their administration to the
8-week-old B6.SJL3C3H.SW complete donor chimeras that
were pretreated with vehicle or imiquimod. As DLI, we used
puriﬁed donor T cells from the B6.PL-Thy1a mice that differ in the
expression of Thy 1.1 allele. In the imiquimod treated group, the
expansion of DLI-derived Thy 1.1 T cells in LNs and spleen was
signiﬁcantly better than that of the vehicle-treated group. This
augmented DLI-mediated GVH response was also reﬂected by a
higher number of DLI-derived CD8 INF- secreting T cells and
by an increase in donor-derived LC chimerism in the imiquimod-
treated group. Next, we tested the effect of imiquimod on the GVL
reactivity of DLI. Four-week-old C3H.SW3C57/BL6 chimeras
constructed after lethal conditioning were pretreated with imi-
quimod prior to DLI administration and lethal challenge with
C1498 leukemia cells. Chimeras that received imiquimod and DLI
had superior leukemia-free survival in comparison to animals that
received DLI plus vehicle (P  .01) or imiquimod alone (P  .02).
The superior leukemia-free survival in the group that received DLI
plus imiquimod correlated also with faster conversion to full donor
CD8 T cell chimerism in comparison to the DLI plus vehicle
group (P  .01). In both models, we have not observed any
signiﬁcant clinical signs of GVHD. These results indicate that
imiquimod, through its action on LCs, can be used to enhance the
DLI-mediated alloimmune responses including their GVL reac-
tivity without exacerbating GVHD.
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SIGNIFICANT DECREASE IN CORD BLOOD (CB) VERSUS ADULT PE-
RIPHERAL BLOOD (APB) MONOCYTE (MO)–DERIVED DENDRITIC CELL
(DC) GENE AND PROTEIN EXPRESSION PATTERNS AND T CELL FUNC-
TIONAL ACTIVATION: INSIGHT INTO IMMATURITY OF CB CELLULAR
IMMUNITY
Jiang, H.1, Wade-Harris, C.1, Baxi, L.2, Cairo, M.S.1,3,4 1. Depart-
ment of Pediatrics, Columbia University, New York, NY; 2. Department
of Obstetrics & Gynecology, Columbia University, New York, NY; 3.
Department of Medicine, Columbia University, New York, NY; 4.
Department of Pathology, Columbia University, New York, NY.
It has been recognized that dysfunction of CB cellular immunity
is in part due to the immaturity of the CB cellular immune system
(Cairo, 1997). However, biological pathways and molecular mech-
anisms associated with the immaturity of CB cellular immunity are
still poorly understood. Recently we have utilized oligonucleotide
microarray to examine gene expression proﬁle of CB vs APB Mo
and have demonstrated signiﬁcant differential gene expression pat-
terns (Jiang/Cairo, 2004). In the current study, differential ex-
pressed genes and proteins were examined in Mo-derived CB vs
APB DC by means of oligonucleotide microarray and proteomics.
Brieﬂy, Mo were puriﬁed and cultured for 8 days with GM-CSF,
IL-4 and LPS. Oligonucleotide microarray was carried out (Af-
fymetrix). The proteomic study was conducted by liquid chroma-
tography (LC) and tandem mass spectrometry (MS/MS). We iden-
tiﬁed gene expression patterns that were signiﬁcantly lower in CB
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